Publicaciones (68) Publicaciones de Enrique de Álava Casado

2022

  1. Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

    Clinical and Translational Oncology, Vol. 24, Núm. 5, pp. 809-815

  2. Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness

    Frontiers in Cell and Developmental Biology, Vol. 10

2021

  1. Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma

    Frontiers in Cell and Developmental Biology, Vol. 9

2018

  1. Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH

    Clinical and Translational Oncology, Vol. 20, Núm. 4, pp. 443-447

  2. Proposal of the SEOM, SEAP and SEFH for the creation of a National Strategy for Precision Medicine in Cancer

    Revista Espanola de Patologia

2017

  1. Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: A position statement of SEOM, SEAP and SEFH

    Farmacia Hospitalaria, Vol. 41, Núm. 6, pp. 688-691

2010

  1. In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma

    Haematologica, Vol. 95, Núm. 5, pp. 794-803

2009

  1. A histological study of the barrier effect of the physis against metaphyseal osteosarcoma

    Pediatric Bone Sarcomas: Epiphysiolysis Before Excision (Springer London), pp. 71-78

  2. DNA DSBs Induction by Zalypsis, a Novel Marine Compound, Results in Potent Antimyeloma Activity

    CLINICAL LYMPHOMA & MYELOMA

  3. Zalypsis: A novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks

    Blood, Vol. 113, Núm. 16, pp. 3781-3791

2008

  1. Primary mixed squamous carcinoma and osteosarcoma (carcinosarcomas) of the lung have a CGH mapping similar to primitive squamous carcinomas and osteosarcomas

    Diagnostic Molecular Pathology, Vol. 17, Núm. 3, pp. 151-158

2007

  1. EWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine model

    Journal of Molecular Medicine, Vol. 85, Núm. 9, pp. 1015-1029

  2. Pseudomesotheliomatous carcinoma of the lung with a distinct morphology, immunohistochemistry, and comparative genomic hybridization profile

    Annals of Diagnostic Pathology, Vol. 11, Núm. 4, pp. 241-251

2005

  1. Gene expression profile of Ewing sarcoma cell lines differing in their EWS-FLI1 fusion type

    Journal of Pediatric Hematology/Oncology, Vol. 27, Núm. 10, pp. 537-542

  2. Insuficiencia respiratoria neonatal asociada a mutación en el gen de la proteína C del surfactante

    Anales de Pediatria, Vol. 62, Núm. 3, pp. 210-214

  3. Insuficiencia respiratoria neonatal asociada a mutación en el gen de la proteína C del surfactante

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 62, Núm. 3, pp. 210-214

2004

  1. Imatinib Inhibits Proliferation of Ewing Tumor Cells Mediated by the Stem Cell Factor/KIT Receptor Pathway, and Sensitizes Cells to Vincristine and Doxorubicin-Induced Apoptosis

    Clinical Cancer Research, Vol. 10, Núm. 2, pp. 751-761

2003

  1. Angiomyolipoma and PEComa are immunoreactive for MyoD1 in cell cytoplasmic staining pattern

    Applied Immunohistochemistry and Molecular Morphology, Vol. 11, Núm. 2, pp. 156-160

  2. Molecular diagnosis of Ewing tumor

    UPDATE IN PATHOLOGY, PROCEEDINGS

  3. PTEN protein expression correlates with PTEN gene molecular changes but not with VEGF expression in astrocytomas

    Diagnostic Molecular Pathology, Vol. 12, Núm. 3, pp. 160-165